Compounds > dronabinol
Page last updated: 2024-08-21

dronabinol and ALS - Amyotrophic Lateral Sclerosis

dronabinol has been researched along with ALS - Amyotrophic Lateral Sclerosis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Lou, K; Murphy, S; Talbot, C1
Funke, A; Kettemann, D; Maier, A; Meyer, T; Münch, C; Spittel, S; Thomas, A; Walter, B1
de Lago, E; Espejo-Porras, F; Fernández-Ruiz, J; Moreno-Martet, M1
Bernardi, G; Carrì, MT; Centonze, D; Cozzolino, M; De Chiara, V; Maccarrone, M; Mercuri, NB; Musella, A; Rossi, S1
Goldman, B; Truniger, S; Weber, M1
Baldinger, R; Brenneisen, R; Fagagnini, S; Goldman, B; Joerger, M; Schneider, U; Weber, M; Wilkins, J1
Abood, ME; McAllister, SD; Moore, DH; Patel, SG; Raman, C; Rizvi, G1
Hong, S; Kliot, M; Möller, T; Stella, N; Weydt, P; Witting, A1

Trials

2 trial(s) available for dronabinol and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial.
    Journal of neurology, neurosurgery, and psychiatry, 2010, Volume: 81, Issue:10

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Appetite; Cross-Over Studies; Depression; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Muscle Cramp; Quality of Life; Severity of Illness Index; Sleep Wake Disorders

2010
Single-dose pharmacokinetics and tolerability of oral delta-9- tetrahydrocannabinol in patients with amyotrophic lateral sclerosis.
    Drug metabolism letters, 2012, Jun-01, Volume: 6, Issue:2

    Topics: Administration, Oral; Adult; Aged; Amyotrophic Lateral Sclerosis; Cannabinoid Receptor Agonists; Dose-Response Relationship, Drug; Dronabinol; Female; Heart Rate; Humans; Male; Middle Aged; Models, Biological; Prospective Studies

2012

Other Studies

6 other study(ies) available for dronabinol and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
Cannabinoids for the treatment of refractory neuropathic pruritus in amyotrophic lateral sclerosis: A case report.
    Palliative medicine, 2022, Volume: 36, Issue:1

    Topics: Amyotrophic Lateral Sclerosis; Cannabinoids; Dronabinol; Humans; Middle Aged; Pain; Pruritus

2022
Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD).
    BMC neurology, 2019, Sep-07, Volume: 19, Issue:1

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Cannabidiol; Cohort Studies; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Muscle Spasticity; Patient Satisfaction; Retrospective Studies

2019
Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1(G93A) transgenic mice and evaluation of a Sativex(®) -like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis.
    CNS neuroscience & therapeutics, 2014, Volume: 20, Issue:9

    Topics: Age Factors; Amyotrophic Lateral Sclerosis; Analysis of Variance; Animals; Cannabidiol; Dronabinol; Drug Combinations; Endocannabinoids; Female; Gene Expression Regulation; Humans; Male; Mice, Transgenic; Phospholipase D; Plant Extracts; Receptors, Cannabinoid; Sex Factors; Spinal Cord; Superoxide Dismutase

2014
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis.
    Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 2010, Volume: 11, Issue:1-2

    Topics: Amyotrophic Lateral Sclerosis; Animals; Corpus Striatum; Disease Models, Animal; Dronabinol; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Genotype; Glutamic Acid; Male; Mice; Mice, Mutant Strains; Nerve Degeneration; Neural Inhibition; Neuroprotective Agents; Receptor, Cannabinoid, CB1; Superoxide Dismutase; Superoxide Dismutase-1; Synaptic Transmission

2010
Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid.
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 2004, Volume: 5, Issue:1

    Topics: Age Factors; Amyotrophic Lateral Sclerosis; Animals; Cannabinoids; Cell Count; Cell Death; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Embryo, Mammalian; Humans; L-Lactate Dehydrogenase; Mice; Mice, Transgenic; Motor Neurons; Piperidines; Psychomotor Performance; Pyrazoles; Rimonabant; Spinal Cord; Superoxide Dismutase; tert-Butylhydroperoxide; Time Factors

2004
Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival.
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 2005, Volume: 6, Issue:3

    Topics: Age Factors; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Disease Progression; Dronabinol; Male; Mice; Mice, Transgenic; Probability; Psychotropic Drugs; Superoxide Dismutase; Survival

2005